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doi:10.1016/j.ejvs.2008.06.022Abstract Objectives: The aim of this study was to assess different techniques of saphenofe-
moral ligation in the treatment of primary varicose veins.
Methods: One hundred and eighty-two patients (210 legs) with primary saphenofemoral junc-
tion incompetence were randomised to standard saphenofemoral ligation (transfixion with an
absorbable suture) (SSL) or flush saphenofemoral ligation (oversewing with 4/0 polypropylene)
(FSL). All legs underwent additional great saphenous vein stripping and multiple phlebec-
tomies. Patients underwent assessment preoperatively, and at 6 weeks, 1 year and 2 years
postoperatively with clinical examination, duplex imaging and completion of the Aberdeen
Varicose Vein Symptom Severity Score (AVVSSS).
Results: A total of 148 patients (172 legs) attended follow-up at 2 years postoperatively.
Recurrent varicose veins were visible in 30 legs (33 per cent) in the SSL group and 26 legs
(32 per cent) in the FSL group (PZ 0.90). Neovascularisation was present in 20 groins
(22 per cent) in the SSL group and 15 groins (19 per cent) in the FSL group (PZ 0.57). Nine
cases of neovascularisation in the SSL group and five in the FSL group directly resulted in clin-
ical recurrence (PZ 0.37).
Conclusions: Flush ligation of the saphenofemoral junction confers no advantage over standard
ligation with respect to clinical recurrence and neovascularisation.
Registration number: ISRCTN20235689 (http://www.controlled-trials.com).
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ty for Vascular Surgery. PublisheIntroduction
Surgery in the form of saphenofemoral ligation (SFL), great
saphenous vein (GSV) stripping and multiple phlebectomies
remains the gold standard treatment for primary great
saphenous varicose veins. Unfortunately, recurrence rates
remain high, despite attempts to improve outcomes byd by Elsevier Ltd. All rights reserved.
Fig. 2 Diagram showing flush saphenofemoral ligation.
Table 1 Patient characteristics
Standard
saphenofemoral
ligation group
(SSL)
Flush
saphenofemoral
ligation group
(FSL)
Patients (n) 95 87
Legs (n) 114 96
Bilateral surgery 19 9
478 R.J. Winterborn et al.ensuring that procedures are performed by appropriately
trained surgeons.1 The majority of research aimed at
decreasing recurrence has concentrated on the role of
stripping the GSV.2e5 Previous research from this institution
has shown that whilst stripping the GSV reduces the rate of
early recurrence the long-term rate of recurrence is the
same.1 The duplex-findings from this study also revealed
that the majority of recurrence was secondary to neovascu-
larisation at the saphenofemoral junction (SFJ).6 A number
of theories have been postulated to explain the phenom-
enon of neovascularisation including the idea that
hypoxia-induced activation of the vascular endothelial cells
lining the residual saphenofemoral stump may stimulate
angiogenesis by the release of growth factors.7e9
Standard transfixion ligation of the SFJ leaves a funnel of
tissue which is lined by endothelium and therefore may act
as a stimulus to new vessel growth. (Fig. 1) An alternative
technique is to oversew the SFJ as close as possible to the
common femoral vein (CFV), therefore decreasing the
amount of exposed endothelium. (Fig. 2)
The aim of this randomised trial was to determine
whether the surgical technique employed affected the
outcome with respect to rates of recurrence and neo-
vascularisation at 2 years postoperatively.
Methods
Study design
The study was a prospective, randomised, single-blinded
trial conducted by a single surgical team at Gloucestershire
Royal Hospital, United Kingdom, between February 2003
and November 2004. The study was approved by the Local
Hospital Ethics Committee.
All patients assessed in the surgical outpatient depart-
ment and listed for primary SFL, GSV stripping and multiple
phlebectomies were eligible to take part in the study.
Those with concomitant saphenopopliteal disease were
excluded. Eligible patients were sent a study information
leaflet, consent form and disease-specific quality of life
questionnaire (Aberdeen Varicose Vein Symptom Severity
Score (AVVSSS)). Patients were invited to return
a completed consent form and AVVSSS if they were willing
to take part in the study. All study participants underwent
pre-operative venous duplex imaging.Fig. 1 Diagram showing standard transfixion saphenofemoral
ligation.Study population
Between February 2003 and November 2004, 304 legs in 260
patients met the inclusion criteria. One-hundred and
eighty-two patients (210 legs) agreed to participate and
gave their written, informed consent. Ninety-five patients
(114 legs) were randomised to standard saphenofemoral
ligation (SSL), and 87 patients (96 legs) were randomised to
flush saphenofemoral ligation (FSL). Patient characteristics
are shown in Table 1.
Randomisation and blinding
Randomisation was performed using sealed envelopes and
the random number generator with varying block sizes in
SPSS version 11.5. Envelopes were opened on, or as close as
possible to the day of surgery. It was not possible to open all
envelopes on the day of surgery as some procedures were
performed at peripheral hospitals and the co-ordinator was
not always available on the day of surgery to open the nextAge, mean SD 47.3  12.3 52.6  14.4
Female: Male 69:26 56:31
Right leg: Left leg 52:62 45:52
Pre-operative CEAP
class 2
55 53
Pre-operative CEAP
class 3
23 11
Pre-operative CEAP
class 4
21 17
Pre-operative CEAP
class 5
4 5
Pre-operative CEAP
class 6
8 8
Pre-operative CEAP
class not documented
3 2
Table 2 Grade of first operator performing procedure
Standard
saphenofemoral
ligation group
(SSL)
Flush
saphenofemoral
ligation group (FSL)
Consultant Surgeon 33 20
Associate Specialist
Surgeon
20 12
Specialist Registrar 49 52
Senior House Officer 8 6
Missing data 4 5
Chi-squared test, PZ 0.31.
Allocated to standard group (SSL)
(n= 95 patients (114 legs)) 
Received allocated intervention 
(n= 95 patients (114 legs)) 
Did not receive allocated intervention
(n= 0 patients (0 legs)) 
Lost to follow-up at 6 weeks (n= 7 legs)
Lost to follow-up at 1 year    (n= 20 legs) 
Lost to follow-up at 2 years  (n= 23 legs) 
Analysed at 6 weeks (n= 107 legs) 
Analysed at 1 year    (n= 94 legs) 
Analysed at 2 years  (n= 91 legs) 
Randomized (n= 182 p
Assessed for elig
(n = 260 patients
Fig. 3 Flow of patie
Randomised Trial of Flush Saphenofemoral Ligation 479envelope. Patients rather than individual legs were rando-
mised; therefore those with bilateral varicose veins had the
same procedure performed on both legs. Both the patient
and the clinician performing the postoperative clinical
assessments and duplex imaging were blinded to the
surgical technique performed.
Venous duplex imaging
Duplex imaging was performed by a trained technologist
using an ATL HDI 5000 colour duplex scanner with a 4e7 MHz
linear array transducer. Patients underwent scanning in
a sitting position with their legs dependent. Reflux of
greater than one second after manual calf compression
was taken to signify incompetence. Valsava’s manoeuvre
was performed if no reflux was detected with calf compres-
sion. A whole-leg duplex scan was undertaken withDeclined to participate 
(n= 78 patients) 
Allocated to Flush group (FSL)
(n= 87 patients (96 legs)) 
Received allocated intervention 
(n= 86 patients (95 legs)) 
Did not receive allocated intervention
(n= 1 patients (1 legs)) 
Reason – operation cancelled 
Analysed at 6 weeks (n= 92 legs) 
Analysed at 1 year    (n= 87 legs) 
Analysed at 2 years  (n= 81 legs) 
atients (210 legs)) 
Lost to follow-up at 6 weeks (n= 3 legs) 
Lost to follow-up at 1 year    (n= 9 legs) 
Lost to follow-up at 2 years  (n= 14 legs) 
ibility
 (304 legs)) 
nts through trial.
Table 3 Level to which GSV was stripped
Standard
saphenofemoral
ligation group
(SSL)
Flush
saphenofemoral
ligation group
(FSL)
GSV stripped to just
below knee
67 50
GSV stripped to knee 21 24
GSV stripped to just
above knee
11 13
GSV reverse stripped 1 1
Failed to strip
GSV e multiple
phlebectomies only
10 2
Chi-squared test, PZ 0.51.
480 R.J. Winterborn et al.documentation of any reflux in the deep and superficial
veins. All named vessels and their variants were assessed
and varicosities mapped. Neovascularisation was defined
as the presence of serpentine venous tributaries entering
the CFV at the site of the old SFJ after calf compression or
Valsava’s manoeuvre. A clinical grading system was used
to describe the degree of neovascularisation.
Grade 0: no neovascularisation.
Grade 1: <3 mm diameter vessels.
Grade 2: >3 mm diameter vessels with visible reflux.
No comment was consistently made on the size of the
tributaries. Incompetent perforating veins were defined as
those with bi-directional flow on calf compression. In
general it was not possible to determine the surgical
technique performed.
Surgical technique
All operations were performed under general anaesthesia
by a trained surgeon. Table 2 shows the number of opera-
tions performed by each grade of surgeon for each group
(PZ 0.31).
Patients undergoing bilateral leg surgery and those with
risk factors for thromboembolic disease received 20 mg
Enoxaparin subcutaneously perioperatively. Surgical tech-
nique involved standard exposure of the SFJ with adequate
exposure of the CFV (approximately 2e3 cm). All
tributaries were diathermy avulsed, at least back to their
first division. SSL involved dividing the GSV between hae-
mostats as close as possible to the CFV. The stump was
transfixed using a 3/0 polyglycolic acid suture. FSL was per-
formed by placing a C-clamp at the origin of the GSV and
dividing it, leaving a small cuff which was oversewn with
4/0 polypropylene. An attempt was made to strip the GSV
using a perforate invaginate (PIN) stripper in all cases.
Large anterior accessory saphenous veins were also strip-
ped. Remaining tributaries were avulsed using Oesch hooks
or fine mosquito forceps.
Postoperative assessment and follow-up
examination
All study patients underwent assessment at 6 weeks, 1 year
and 2 years postoperatively with clinical examination and
venous duplex imaging. Complications of surgery were
documented at the 6-week visit and patients were asked
to comment on their degree of satisfaction with the surgical
outcome at each follow-up appointment. Recurrent vari-
cose veins were defined as any new visible varicosity on
clinical examination at 1 and 2 years postoperatively.
Outcome measures
The primary outcome measure was clinical recurrence (any
new visible varicosity) at 2 years post-operatively. The
secondary outcome measure was the presence of neo-
vascularisation at the SFJ at 2 years post-operatively.
Comparisons were also made between the groups with
regard to grades of neovascularisation, neovascularisation
connecting to vessels in the thigh and neovascularisation
causing recurrent varicose veins. Tertiary outcomemeasures included complication rates, patient satisfaction,
and quality of life data.
Statistical analysis
Sample size was calculated on the basis of the primary
outcome measure. Previous research from this centre has
shown clinical recurrence rates of 25 per cent at 2 years
following SSL and GSV stripping. Data regarding recurrence
rates following oversewing of the junction are scarce. The
expected clinical recurrence rate for FSL was therefore set
at 10%. An enrolment of 98 legs in each group was therefore
required to achieve a 5% two-tailed probability of a type I
error and a 20% probability of a type II error.
Clinical data were compared using the Chi-squared test
and AVVSSS scores were compared using paired and
unpaired t-tests. P< 0.05 was considered statistically
significant.
Results
Between April 2003 and November 2004, 114 legs in 95
patients underwent standard saphenofemoral ligation (SSL)
and 95 legs in 86 patients underwent flush saphenofemoral
ligation (FSL). Fig. 3 shows the flow of patients through the
study. Successful SFL was documented for all patients. The
degree to which the GSV was successfully stripped is shown
in Table 3; there was no statistically significant difference
between the groups (PZ 0.51).
6-week follow-up
Eighty-nine patients (107 legs) in the SSL group and 79
patients (92 legs) in the FSL group attended early follow-
up. One patient withdrew from the study for personal
reasons and the remainder were lost to follow-up. Twelve
legs in the SSL group and 2 in the FSL group reported groin
wound infections (PZ 0.01). A total of 4 legs developed
a groin haematoma, 3 in the FSL group (PZ 0.24). Three
legs developed a seroma, 2 in the FSL group (PZ 0.47).
Twenty-three legs (21 per cent) in the SSL group and
27 legs (29 per cent) in the FSL group developed cutaneous
67%
7%16%
10%
Recurrence above knee
Recurrence below knee
Recurrence above and below knee
No Recurrence
68%
5%
17%
10%
Recurrence above knee
Recurrence below knee
Recurrence above and below knee
No Recurrence
b
a
Fig. 4 (a). Recurrence rates for standard saphenofemoral
ligation group. (b). Recurrence rates for flush saphenofemoral
ligation group.
Randomised Trial of Flush Saphenofemoral Ligation 481numbness (PZ 0.60). Two patients in the SSL group devel-
oped a below knee deep vein thrombosis (DVT) and a further
patient had a non-fatal pulmonary embolism; one of the
patients who developed a DVT did not receive peri-opera-
tive thromboprophylaxis as they were considered to be
low-risk. One patient in the FSL group had a non-fatal
peri-operative myocardial infarction. Nineteen legs (18
per cent) in the SSL group and 24 legs (26 per cent) in the
FSL group had residual varicose veins either above or below
or the knee, at 6-week follow-up (PZ 0.21). Seventy-eight
patients, 89 legs in the SSL group (83 per cent) and 81
patients, 85 legs in the FSL group (92 per cent) were happy
with the results of surgery (PZ 0.14). Four patients, 4 legs
in the SSL group and 2 patients, 2 legs in the FSL group were
not happy with the results of surgery. The remainder were
neither happy nor unhappy with the result. Quality control
duplex imaging revealed a total of 5 legs in the SSL group
and 1 leg in the FSL group in which the SFJ remained
present (PZ 0.14). In 1 leg in the SSL group and 1 leg inTable 4 Grades of neovascularisation and connection with thig
No neovascularisation (Grade 0)
Neovascularisation< 3 mm (Grade 1)
Neovascularisation> 3 mm (Grade 2)
Neovascularisation> 3 mm connecting to competent thigh vein
Neovascularisation> 3 mm connecting to incompetent thigh vein
Neovascularisation> 3 mm connecting to incompetent thigh vein
causing recurrence
*Chi-squared test.the FSL group it remained present and incompetent, repre-
senting a failure to identify the SFJ correctly. In the
remaining 4 legs the SFJ was competent pre and post-oper-
atively, however, there was still a failure to identify and
ligate the SFJ.
1-year follow up
Seventy-nine patients (94 legs) in the SSL group and 75
patients (87 legs) in the FSL group attended follow-up at
1 year postoperatively. Three patients (4 legs) had moved
away from the area, 1 patient (2 legs) died of unrelated
causes, 1 patient had already withdrawn and the remainder
were lost to follow-up. Seven legs in the SSL group and
11 legs in the FSL group had ongoing cutaneous numbness
(PZ 0.24). Residual varicose veins remained visible in 5 legs
(5 per cent) in the SSL group and 10 legs (11 per cent) in the
FSL group (PZ 0.29). Recurrent varicose veins had devel-
oped and were visible in 19 legs (20 per cent) in the SSL
group and 10 legs (11 per cent) in the FSL group
(PZ 0.11). Thigh varicosities were visible in 5 legs (5 per
cent) in the SSL group, but only one leg (1 per cent) in the
FSL group (PZ 0.13).
Duplex imaging showed groin neovascularisation in
20 legs (21 per cent) in the SSL group, and 12 legs (14 per
cent) in the FSL group (PZ 0.08). The neovascularisation
connected to a thigh vessel in 7 legs (7 per cent) in the
SSL group and 3 legs (3 per cent) in the FSL group
(PZ 0.24). This lead to clinical recurrence in 4 legs (4 per
cent) and 2 legs (2 per cent) respectively (PZ 0.46).
Seventy-two patients, 82 legs in the SSL group (87 per
cent), 73 patients, 80 legs in the FSL group (92 per
cent)(PZ 0.29) remained happy with the results of surgery.
2-year follow-up
Seventy-five patients (91 legs) in the SSL group and
73 patients (81 legs) in the FSL group attended follow-up
at 2 years postoperatively. The reasons for failure to attend
follow-up were as documented at 1-year postoperatively.
Recurrent varicose veins were visible in 30 legs (33 per
cent) in the SSL group (Fig. 4a) and 26 legs (32 per cent) in
the FSL group (PZ 0.90). (Fig. 4b) Neovascularisation was
present in 20 legs (22 per cent) in the SSL group and
15 legs (19 per cent) in the FSL group (PZ 0.57). Table 4
shows grades of neovascularisation and connection with
a thigh vein. Neovascularisation was the cause ofh vein at 2-year follow-up
Standard saphenofemoral
ligation group (SSL)
Flush saphenofemoral
ligation group (FSL)
P value*
71 66 PZ 0.26
5 3 PZ 0.57
15 12 PZ 0.76
4 0 PZ 0.06
9 5 PZ 0.37
9 5 PZ 0.37
Table 5 Comparison of quality of life scores
Standard saphenofemoral
ligation group (Mean with S.D.)
Flush saphenofemoral ligation
group (Mean with SD)
P value*
Mean Preoperative AVVSSS 19.15 S.D. 10.60 18.33 S.D. 10.11
Mean 6-week AVVSSS 9.93 S.D. 9.70 7.55 S.D. 6.87 PZ 0.07
Mean 1-year AVVSSS 6.78 S.D. 7.32 6.25 S.D. 5.73 PZ 0.62
Mean 2-year AVVSSS 8.42 S.D. 9.21 8.83 S.D. 8.24 PZ 0.78
*Comparison of means at each follow-up point using unpaired t-test.
482 R.J. Winterborn et al.recurrence in 9 legs (10 per cent) in the SSL group and 5 legs
(6 per cent) in the FSL group (PZ 0.37).
The degree of patient satisfaction remained 87 per cent
for the SSL group but decreased to 78 per cent for the FSL
group (PZ 0.40). No patients underwent treatment for
recurrent varicose veins during the study period.
Quality of life analysis
There was no statistically significant difference in AVVSSS
between the SSL group and the FSL group at any time point.
(Table 5) There was a statistically significant improvement
in AVSSS at 6 weeks, 1 year and 2 years following surgery
for both groups (P< 0.001).
Conclusions
The surgical treatment of varicose veins has changed very
little over the last century. Many studies have explored the
importance of stripping the GSV with a wide range of
reported recurrence rates (7 to 65 per cent).3,5,6,10,11 Studies
from this institution have shown no difference in long-term
recurrence, but a reduction in re-operation rates with
routine stripping.1 A number of centres have studied the
use of barrier techniques in the search for a method of
decreasing recurrence secondary to neovascularisation.12e15
Gibbs used a reflected flap of pectineus fascia and showed
nodifference in re-recurrence rates in patientswith recurrent
varicose veins.16 A number of different synthetic materials
have been used including silicone patches and polytetra-
fluoroethylene (PTFE) patches. De Maeseneer showed lower
rates of neovascularisation in patients who had a silicone
patch inserted over the ligated SFJ.13,14 In our institution we
haveexplored theuseofPTFEpatches.Whilst thepilot studies
showed promising results a randomised trial of patients with
recurrent varicose veins showed no improvement in the rates
of neovascularisation.17,18
Few have studied different techniques of performing the
SFL itself. There have been reports of using microclips
rather than suture material19 and of leaving a long stump
in order that the walls of the funnel of GSV flop together,
decreasing the amount of exposed endothelium.20 The
only randomised trial of different ligature techniques was
performed by Frings et al. They randomised 500 legs into
different operative groups. Groups A and B underwent SFL
with an absorbable 0 Vicryl suture. Groups C and D under-
went SFL with a non-absorbable Ethibond suture. In addi-
tion, a continuous Prolene was sutured over the stump
in groups B and D. Unfortunately, only 152 legs were fol-
lowed up at 2 years postoperatively. Whilst the rates ofneovascularisation were low (3 legs, 0 legs, 5 legs and 2
legs respectively), statistical analysis showed no difference
in the rate of recurrent saphenofemoral incompetence.21
Jaeschok also studied this technique but the follow-up
interval was only 3 months.22
This study is the first to compare standard transfixion
ligation with oversewing of the junction, flush with the CFV.
The strengths of this study are that it is a randomised,
single-blinded trial with 2-year follow-up involving clinical
examination and detailed duplex imaging. As has been the
case in previous studies on patients with varicose veins
those requiring bilateral surgery had the same procedure
performed on both legs. This helps to account for the
difference in numbers of legs between the groups. The
number of patients attending follow-up at each time point
was reasonable although we should have allowed for
a larger drop out rate when calculating the numbers
required. The catchment area for Gloucestershire Royal
Hospital is wide and therefore many patients had to travel
significant distances to attend follow-up appointments.
The 6-week follow-up served to assess complication
rates and allow quality control of the surgery by duplex
imaging. The rates of infection were high; however, these
were patient reported infections. The difference between
the two groups was statistically significant (PZ 0.01).
Perhaps more attention was paid to meticulous haemostasis
in those patients who underwent oversewing of the junc-
tion, alternatively it could be related to the fact that the
absorbable suture was braided and the non-absorbable
suture was a monofilament. One could argue, with this
rate of infection, that all patients having SFL should receive
a dose of perioperative antibiotics. The rising rate of
hospital-acquired infections, however, is a strong argument
against this. The rate of numbness was similar to previous
studies.23e25 The remaining complications are a conse-
quence of the volume of cases performed and serve as
a reminder that varicose vein surgery does occasionally
result in complications. The number of legs with residual
varicose veins at 6 weeks was surprisingly high (22 per
cent), although the majority were below the knee and
many disappeared by one-year postoperatively (1-year
rate, 8 per cent). The most striking finding at 6 weeks
was the rate of surgical failures. Much emphasis is placed
on the importance of the grade and experience of the
surgeon performing the procedure, however, there were 6
legs in which there was failure to accurately identify the
SFJ. Three were performed by a consultant and 3 by
a Specialist Registrar. In 4 legs an incompetent anterior
thigh vein was stripped rather than the GSV. The junction
left behind was competent in all cases. In 2 legs a GSV trib-
utary was removed and in 1 leg there was ongoing
Randomised Trial of Flush Saphenofemoral Ligation 483saphenofemoral incompetence. Interestingly 5 of the 6 fail-
ures were in the standard surgery group; this may be
accounted for by the fact that in order perform flush liga-
tion the surgeon has to expose the junction more clearly
in order to be able to manoeuvre the C-clamp into position.
The primary outcome measure was clinical recurrence at
2 years postoperatively. At 1 year the rate of recurrence in
the standard group was 20 per cent and in the flush group it
was 11 per cent. Whilst the difference was 9 per cent it was
not statistically significantly different (PZ 0.11). At 2 years
the difference between the groups dropped to less than 1
per cent. Even comparing recurrence above the knee there
was no difference. The results cannot be explained by the
drop off in follow-up as of those that did not attend, 2 in
each group had visible vessels in the thigh at 1 year and
none had neovascularisation, therefore it is unlikely that
there would have been more recurrences in the standard
group than the flush group. With regard to the rate of neo-
vascularisation, the overall difference approached signifi-
cance at 1 year, however, at 2 years there was no
difference. Breaking down the groups into grades of neo-
vascularisation, there was a statistically significant differ-
ence for grade 2 neovascularisation at 1 year (PZ 0.03);
however, this had disappeared by 2 years.
The theory behind this study was that the residual
saphenofemoral stump somehow stimulates neovascularisa-
tion. As described in the introduction, it has been suggested
that hypoxia-induced activation of endothelial cells distal
to the stump ligature may encourage new vessel
growth.7,26,27 By performing a flush ligation not only is the
stump removed but an attempt is made to invert the edges
during oversewing in order to decrease the area of exposed
endothelium. This randomised study shows that there is no
reduction in the rate of recurrence or neovascularisation by
performing a flush ligation.
The advent of endovascular techniques and the lack of
associated neovascularisation would suggest that groin
dissection and ligation do play a role, however, haematoma
in the strip-track may also be a factor,28 which is removed
by performing one of the new techniques.
Surgery remains the most commonly performed proce-
dure for varicose veins, despite the high rates of recurrent
varicose veins.29 Proponents of radiofrequency ablation,
endovenous laser treatment and foam sclerotherapy cite
the ability to perform these techniques in an outpatient
setting under local anaesthetic as a reason to consider
switching from conventional surgery. There is, however,
no long-term data on clinical outcomes, although some
authors suggest that there is less post-operative pain and
a faster return to work with radiofrequency ablation.30
There has been a significant amount of research into
different techniques for decreasing neovascularisation. The
results of this study were not positive in favour of over-
sewing the SFJ. The findings serve to close the chapter on
attempts at novel methods of ligation and stripping.References
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